Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231814 Org: User:
Start: 12/31/16 End: 12/31/20 Due: 12/31/21

Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02843100 Org: User:
Start: 04/10/18 End: 05/29/22 Due: 05/29/23

Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation

Phase: N/A Priority: Normal
NCT ID: NCT02269358 Org: User:
Start: 07/31/15 End: 10/09/18 Due: 10/09/19

Use of the Ulcerative Colitis Diet for Induction of Remission

Phase: N/A Priority: Normal
NCT ID: NCT02217722 Org: User:
Start: 10/31/14 End: 02/29/16 Due: 02/28/17

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01596894 Org: User:
Start: 10/31/12 End: 12/31/15 Due: 12/31/16

Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01728870 Org: User:
Start: 01/31/13 End: 07/31/18 Due: 07/31/19

Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03980405 Org: User:
Start: 04/01/20 End: 05/30/22 Due: 05/30/23

Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02345733 Org: User:
Start: 09/01/15 End: 10/29/21 Due: 10/29/22

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

Phase: N/A Priority: Normal
NCT ID: NCT01802593 Org: User:
Start: 02/28/13 End: 12/31/15 Due: 12/31/16